AGEN Market Cap History
Below is a table of the AGEN market cap history going back to 10/3/2011:

Date AGEN Market Cap
10/3/201150.25M
11/2/201158.14M
2/24/201272.43M
5/4/2012142.86M
8/3/2012116.70M
11/2/2012109.94M
2/22/2013110.05M
5/9/2013122.84M
8/5/2013113.02M
11/4/201387.62M
2/24/2014261.75M
4/30/2014176.75M
7/28/2014202.45M
10/27/2014190.56M
2/24/2015382.10M
4/27/2015517.56M
7/24/2015721.67M
10/30/2015385.99M
2/29/2016239.65M
5/2/2016320.60M
7/29/2016482.85M
11/2/2016331.95M
2/28/2017416.91M
4/26/2017368.72M
7/31/2017442.72M
11/2/2017363.66M
2/28/2018552.78M
5/4/2018382.72M
8/3/2018197.11M
11/2/2018226.77M
3/11/2019371.75M
5/6/2019362.50M
8/5/2019297.97M
12/31/20185.34M
11/1/2019391.48M
3/12/2020421.75M
5/7/2020431.23M
3/15/2021695.93M

Also see: AGEN Shares Outstanding History
and AGEN YTD Return
AGEN Historical Market Cap:
+32.05% CAGR
AGEN Historical Market Cap: +32.05% CAGR

Mouse over chart for data details
10/3/2011 ...3/15/2021
Agenus is a clinical-stage immuno-oncology company engaged in the development of a pipeline of immune checkpoint antibodies, adoptive cell therapies and neoantigen cancer vaccines, to fight cancer. Co.'s antibody candidates are balstilimab (an anti-PD-1 antibody) and zalifrelimab (an anti-CTLA-4 antibody), which are in trials of balstilimab monotherapy and balstilimab/zalifrelimab combination for patients with second-line cervical cancer. Co. is also developing its proprietary anti-CTLA-4 antibody, AGEN1181, which is designed to expand the population of patients benefiting from anti-CTLA-4 therapy. Co.'s AgenTus Therapeutics, Inc. subsidiary focuses on allogeneic cell therapies. We show 38 historical shares outstanding datapoints in our AGEN shares outstanding history coverage, used to compute AGEN market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing AGEN market cap history over the course of time is important for investors interested in comparing AGEN's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of AGEN versus a peer is one thing; comparing AGEN market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like AGEN can fluctuate over the course of history. With this page we aim to empower investors researching AGEN by allowing them to research the AGEN market cap history.
Quotes delayed 20 minutes
Get Free SEC filing alerts for AGEN:
AGEN SEC Filing Email Alerts ServiceExternal link
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Agenus (AGEN) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

AGIO Market Cap History
AGLE Market Cap History
AGN Market Cap History
AGRX Market Cap History
AGTC Market Cap History
AHPI Market Cap History
AIMT Market Cap History
AIQ Market Cap History
AKAO Market Cap History
AKBA Market Cap History
More Healthcare companies »

 

AGEN Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2021, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.